The reflux testing products market has seen considerable growth due to a variety of factors.
•The market size of reflux testing products has seen consistent growth in the past years. It is projected to increase from $3.32 billion in 2024 to $3.45 billion in 2025, marking an annual compound growth rate (CAGR) of 4.0%.
The notable growth during the historic period is largely due to a rise in GERD prevalence, heightened awareness and diagnostic trends, progress in medical imaging and diagnostics, increased spending on healthcare, and patients' preference for non-invasive tests.
The reflux testing products market is expected to maintain its strong growth trajectory in upcoming years.
• The market for reflux testing products is set to experience significant expansion over the coming years, with expectations to escalate to "$4.4 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 6.3%.
This growth during the forecast period can be linked to the incorporation of multimodal diagnostics, global health programs promoting digestive health, the emergence of telemedicine and remote monitoring, as well as joint research in the field of gastroenterology. In the forecast period, some of the key trends to watch out for include a pivot towards ambulatory monitoring, strategic collaborations and alliances, revisions in reimbursement policies and healthcare regulations, and worldwide economic conditions.
The surge in instances of Barrett's esophagus is anticipated to bolster the expansion of the reflux testing products market. Barrett's esophagus refers to a condition caused by acid reflux destroying the pink and flat lining of the esophagus - the pipe connecting the mouth to the stomach - which subsequently leads to its thickening and reddening. Upon healing of the lesion, the normal squamous epithelium gets substituted by columnar epithelium, a quintessential symptom of Barrett's esophagus. This condition is uniquely associated with heightened chances of esophageal cancer. Rising occurrences of Barrett's esophagus will therefore facilitate the growth of reflux testing products market. For example, the National Centre for Biotechnology Information publication posited in January 2023 that an estimated 5.6% adults suffer from Barrett's esophagus in the United States. It was also highlighted that Barrett esophagus could lead to the detection of esophageal cancer in 1 out of 416 individuals (0.24%) each year. Thus, the high occurrence rate of Barrett's esophagus is undoubtedly fuelling the growth of the reflux testing products market.
The reflux testing products market covered in this report is segmented –
1) By Product Type: Catheter Based Testing Products, Capsule Based Testing Products, Reflux Testing Probes, Other Product Types
2) By Disease Indication: Barrett's Esophagus, Reflux Esophagitis, Esophageal Adenocarcinoma
3) By End Users: Hospitals, Clinics, Ambulatory surgical centers, Other End Users
Subsegments:
1) By Catheter Based Testing Products: Esophageal Catheters, PH Monitoring Catheters, Manometry Catheters
2) By Capsule Based Testing Products: Wireless PH Monitoring Capsules, Bravo PH Monitoring Capsules
3) By Reflux Testing Probes: Esophageal Reflux Probes, Impedance Probes
4) By Other Product Types: Reflux Testing Software, Accessories And Consumables
Product innovation is becoming an increasingly prominent trend within the reflux testing products market. To maintain their market positions, leading companies are embracing cutting-edge technologies. For example, in April 2023, Laborie, a medical equipment and devices company from Canada, unveiled alpHaONE, a groundbreaking GERD Diagnostic System. The alpHaONE system, a wireless pH-capsule reflux testing platform, delivers up to 96 hours of continuous monitoring data. It features a minimalist, user-friendly design with large, easy-to-press buttons. It also includes a fail-safe capsule dispensing system to protect the patient's esophagus. Laborie incorporated a software into the alpHaONE system that includes a virtual guide for easier navigation. The pH-capsule reflux testing device ensures a smooth user experience with customizable symptom buttons and automated pH data processing.
Major companies operating in the reflux testing products market include:
• Medtronic PLC
• Biomedix Optotechnik And Devices Private Limited
• Sierra Scientific Instruments
• Respiratory Technology Corporation
• AstraZeneca plc
• Ironwood Pharmaceuticals Inc.
• Johnson & Johnson Services Inc.
• Sebela Pharmaceuticals
• Diversatek Healthcare
• Danish multinational technology company
• Phathom Pharmaceuticals
• Controls Group's
• Takeda Pharmaceutical Company Limited
• Acino International AG
• SKG Internationals
• Restech
• Sandhill Scientific
• Mui Scientific
• Reza Band
• Dr. Frigz International
• MMS Medical
• Medovations
• Given Imaging
• Crospon
• Mederi Therapeutics
• EndoGastric Solutions
• C. R. Bard Inc.
• Interscope Inc.
• Medline Industries Inc.
• Alba Diagnostics
North America was the largest region in the reflux testing products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global reflux testing products market during the forecast period. The regions covered in the reflux testing products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa